FDA clears Biomet's Active Articulation Hip System

Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, today announced clearance of its Active Articulation™ E1® Dual Mobility Hip System, by the United States Food and Drug Administration.

The Active Articulation™ Hip System is Biomet's first hip system in the United States to merge the concept of dual mobility with the benefits of Biomet's exclusive E1^® Antioxidant Infused technology and a proven cup design.

The dual mobility hip concept was developed over 30 years ago and has since experienced clinical success. The concept utilizes a small femoral head that articulates within polyethylene. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup.

"The Active Articulation™ Hip System provides an excellent combination of wear resistance and implant stability," said Jon Serbousek, President of Biomet's U.S. Orthopedics division. "We believe this new product will provide an important implant solution to orthopedic surgeons performing hip replacement surgery."

Source: Biomet, Inc.